The present study, conducted using the 22C3 antibody for immunohistochemical evaluation of tumor PD-L1 expression, showed that positive tumor PD-L1 expression was associated with shorter PFS, consistent with the results reported by Soo et al., who used the SP142 antibody for evaluating tumor PD-L1 expression [14]. Here, CD274 is linked to neoplasm.